Latin America Self-monitoring Blood Glucose Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The report covers Latin America Blood Glucose Test Strip Packaging Market Trends and the market is segmented by Component (Glucometer Devices, Test Strips, and Lancets) and Geography (Mexico, Brazil, and Rest of Latin America). The market provides the value (in USD million) for the above-mentioned segments.

Latin America Self-monitoring Blood Glucose Market Size

View Global Report

Compare market size and growth of Latin America Self -Monitoring Blood Glucose Market with other markets in Healthcare Industry

Latin America Self-monitoring Blood Glucose Market Analysis

The Latin America Self -Monitoring Blood Glucose Market size is estimated at USD 600.23 million in 2025, and is expected to reach USD 751.58 million by 2030, at a CAGR of 4.6% during the forecast period (2025-2030).

Diabetes incidence for type 2 diabetes and other diabetes forms was numerically higher in individuals with Covid-19 in North America. Insulin resistance and impaired insulin secretion have been reported in people who recovered from SARS-CoV-2 infections but had no history of diabetes. It has been suggested that integrated rather than disease-specific approaches are required for the diagnosis and treatment of post-Covid syndrome.

Diabetes is common in Latin American countries, and Mexico is known to have a large number of diabetic patients due to the country's increasing prevalence of Type-2 diabetes. The steadily increasing obesity rate, combined with a genetic predisposition to Type-2 diabetes, has been a major driver of the increase in the Type-2 diabetic population over the last 40 years. Diabetes currently affects nearly 10% of the total population. Type 2 diabetes is the most prevalent type of diabetes in Latin America, accounting for nearly 90% of the total diabetic population in 2021. Argentina, Brazil, Colombia, and Mexico achieved an overall index of essential coverage of 76-77 percent, with households spending less than 25% of their income on health care, according to Universal Health Coverage 2022. Several reports and surveys have documented a significant increase in the diabetic population because of lifestyle and habit changes. The growing diabetic population drives the demand for blood monitoring devices like the SMBG. A glucometer is used by nearly 90% of Type 1 diabetic patients in developed countries. Glucometers are expected to be used by nearly half of Type 2 patients during the forecast period. Access to primary healthcare systems and noncommunicable disease coverage improved service coverage, while an increase in the number of qualified healthcare personnel enabled community outreach.

Therefore, owing to the aforementioned factors the studied market is anticipated to witness growth over the analysis period.

Latin America Self-monitoring Blood Glucose Industry Overview

The Latin America self-monitoring blood glucose market is fragmented, with a few major manufacturers having a global market presence. In contrast, the remaining manufacturers are confined to local or region-specific manufacturers. Mergers and acquisitions that occurred between the players in the recent past have helped companies strengthen their market presence.

Latin America Self-monitoring Blood Glucose Market Leaders

  1. ROCHE

  2. ABBOTT

  3. ARKARY

  4. ASCENSIA

  5. AGAMATRIX

  6. *Disclaimer: Major Players sorted in no particular order
Need More Details on Market Players and Competitors?
Download PDF

Latin America Self-monitoring Blood Glucose Market News

  • June 2022: LifeScan announced that the peer-reviewed journal Diabetes Technology and Therapeutics (DTT) had published Real World Evidence of Improved Glycemic Control in People with Diabetes using a Bluetooth-connected Blood Glucose Meter with Mobile Diabetes Management Application using the OneTouch Reveal mobile app with the OneTouch Verio Reflect meter synced via Bluetooth wireless technology - could support improved glycemic control for people with diabetes.
  • January 2022: Roche launched its new point-of-care blood glucose monitor designed for hospital professionals, with a companion device shaped like a touchscreen smartphone that will run its apps. The hand-held Cobas pulse includes an automated glucose test strip reader, a camera, and a touchscreen for logging other diagnostic results. It's designed for patients of all ages, including neonates and people in intensive care.

Latin America Self-monitoring Blood Glucose Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Drivers
  • 4.3 Restraints
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Bargaining Power of Suppliers
    • 4.4.2 Bargaining Power of Consumers
    • 4.4.3 Threat of New Entrants
    • 4.4.4 Threat of Substitute Products and Services
    • 4.4.5 Intensity of Competitive Rivalry

5. Market Segmentation

  • 5.1 Self-Monitoring Blood Glucose Devices
    • 5.1.1 Glucometer Devices
    • 5.1.2 Blood Glucose Test Strips
    • 5.1.3 Lancets
  • 5.2 Geography
    • 5.2.1 Mexico
    • 5.2.2 Brazil
    • 5.2.3 Rest of Latin America

6. MARKET INDICATORS

  • 6.1 Type-1 Diabetes Population
  • 6.2 Type-2 Diabetes Population

7. COMPETITIVE LANDSCAPE

  • 7.1 Company Profiles
    • 7.1.1 Abbott Laboratories
    • 7.1.2 F. Hoffmann-La Roche AG
    • 7.1.3 Platinum Equity (LifeScan)
    • 7.1.4 Arkray
    • 7.1.5 Ascensia
    • 7.1.6 Agamatrix Inc.
    • 7.1.7 Bionime Corporation
    • 7.1.8 Acon
    • 7.1.9 Medisana
    • 7.1.10 Trivida
    • 7.1.11 Rossmax
  • *List Not Exhaustive
  • 7.2 Company Share Analysis

8. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
*We will provide a segment-wise breakdown (Value and Volume) for all the countries covered under the Table of Contents. **Competitive Landscape Covers - Business Overview, Financials, Products and Strategies, and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Latin America Self-monitoring Blood Glucose Industry Segmentation

When a patient uses a blood glucose meter to check their levels, this is known as self-monitoring blood glucose (SMBG). The best method for diagnosing and treating hypoglycemia is SMBG. It can offer feedback on the effects of programs promoting healthy behavior and antihyperglycemic drug therapies. The Latin America Self-monitoring Blood Glucose Market is segmented by Component (Glucometer Devices, Test Strips, and Lancets) and Geography (Mexico, Brazil, and Rest of Latin America). The report offers market size and forecasts for all the above segments in value (USD million) and volume (unit million). We will provide a segment-wise breakdown (Value and Volume) for all the countries covered under the Table of Contents.

Self-Monitoring Blood Glucose Devices Glucometer Devices
Blood Glucose Test Strips
Lancets
Geography Mexico
Brazil
Rest of Latin America
Self-Monitoring Blood Glucose Devices
Glucometer Devices
Blood Glucose Test Strips
Lancets
Geography
Mexico
Brazil
Rest of Latin America
Need A Different Region or Segment?
Customize Now

Latin America Self-monitoring Blood Glucose Market Research FAQs

How big is the Latin America Self -Monitoring Blood Glucose Market?

The Latin America Self -Monitoring Blood Glucose Market size is expected to reach USD 600.23 million in 2025 and grow at a CAGR of 4.60% to reach USD 751.58 million by 2030.

What is the current Latin America Self -Monitoring Blood Glucose Market size?

In 2025, the Latin America Self -Monitoring Blood Glucose Market size is expected to reach USD 600.23 million.

Who are the key players in Latin America Self -Monitoring Blood Glucose Market?

ROCHE, ABBOTT, ARKARY, ASCENSIA and AGAMATRIX are the major companies operating in the Latin America Self -Monitoring Blood Glucose Market.

What years does this Latin America Self -Monitoring Blood Glucose Market cover, and what was the market size in 2024?

In 2024, the Latin America Self -Monitoring Blood Glucose Market size was estimated at USD 572.62 million. The report covers the Latin America Self -Monitoring Blood Glucose Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Latin America Self -Monitoring Blood Glucose Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

Page last updated on: November 21, 2024

Latin America Blood Glucose Test Strip Packaging Industry Report

Statistics for the 2025 Latin America Self -Monitoring Blood Glucose market share, size and revenue growth rate, created by Mordor Intelligenceâ„¢ Industry Reports. Latin America Self -Monitoring Blood Glucose analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.

Latin America Blood Glucose Test Strip Packaging Market Report Snapshots